Unraveling metabolic reprogramming in cancer with spatial proteomics

This application note explores how modular Imaging Mass Cytometry (IMC^™) panels enable spatial and metabolic profiling of the tumor microenvironment. By integrating the Human Cell Metabolism and Immuno-Oncology IMC panels, researchers can identify metabolic reprogramming in cancer cells, assess immune infiltration, and uncover targets for precision oncology and immunotherapy development.